Clinical Trials Directory

Trials / Completed

CompletedNCT02979223

Combination Method Using Sodium Picosulfate and Magnesium Citrate and PEG With Ascorbic Acid for Bowel Preparation

Comparison the Efficacy Depending on the Order of the Sequential Combination Method Using Sodium Picosulfate and Magnesium Citrate (PMC) and PEG With Ascorbic Acid for Bowel Preparation (The Phase II Prospective Randomized Clinical Trial)

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
142 (actual)
Sponsor
National Cancer Center, Korea · Other Government
Sex
All
Age
20 Years – 70 Years
Healthy volunteers
Accepted

Summary

The aim of this study is to compare the efficacy depending on the order of the sequential combination method using sodium picosulfate and magnesium citrate (PMC) and PEG with ascorbic acid for bowel preparation. The investigators designed this study as a phase II prospective randomized parallel arm clinical trial. 71 participant will be enrolled in each group (142 in total). The primary outcome is the efficacy of bowel preparation. secondary outcomes are tolerability, side effect of the drugs, polyp detection rate and adenoma detection rate.

Conditions

Interventions

TypeNameDescription
DRUGsodium picosulfate and magnesium citrate, polyethylene glycol with ascorbic acidsodium picosulfate and magnesium citrate and 2L polyethylene glycol with ascorbic acid are used as combination method. There is a difference in the order of intake between two group

Timeline

Start date
2016-11-01
Primary completion
2017-06-01
Completion
2017-06-01
First posted
2016-12-01
Last updated
2019-08-28

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT02979223. Inclusion in this directory is not an endorsement.

Combination Method Using Sodium Picosulfate and Magnesium Citrate and PEG With Ascorbic Acid for Bowel Preparation (NCT02979223) · Clinical Trials Directory